QNRX SCHEDULE 13G: SEC filing

Filed with the SEC on · accession 0001104659-26-127778

QNRX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.3% by the first close after the filing.

Summary of the filing

StemPoint Capital LP, along with StemPoint Capital Management GP LLC and Michelle Ross, filed a Schedule 13G disclosing beneficial ownership of approximately 9.9% of Quoin Pharmaceuticals' American Depositary Shares, including shares underlying pre-funded and common warrants.

Key details

Beneficial ownership of American Depositary Shares$507K
Shares of ADS held directly$236K
Shares of ADS underlying pre-funded warrants$174K
Shares of ADS underlying common warrants$97K
Reporting person / beneficial ownerStemPoint Capital LP
Reporting person / general partnerStemPoint Capital Management GP LLC
IssuerQuoin Pharmaceuticals Ltd.
Reporting personMichelle Ross
Authorized signatory, stempoint capital lpSean C. Tan

How QNRX stock reacted

Close before

$3.70

Nov 13, 2026

First close after

-0.27%

$3.69

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for QNRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNRX?

Click here

Frequently asked questions

What did QNRX file with the SEC on Nov 16, 2026?

QNRX filed a SCHEDULE 13G (SEC filing). StemPoint Capital LP, along with StemPoint Capital Management GP LLC and Michelle Ross, filed a Schedule 13G disclosing beneficial ownership of approximately 9.9% of Quoin Pharmaceuticals' American Depositary Shares, including shares underlying pre-funded and common warrants.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did QNRX stock react to this filing?

QNRX closed at $3.70 before the filing and $3.69 on Nov 16, 2026 (-0.27%).

Other QNRX SEC filings

Get alerts when QNRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days